Compare Johnson & Johnson (JNJ) vs Sunrun Inc (RUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Sunrun Inc — how do they compare? Johnson & Johnson trades at $260.84 (market cap $626.09B), while Sunrun Inc trades at $9.81 (market cap $2.42B). The key difference: Johnson & Johnson is far larger — about 258.7× Sunrun Inc's market cap, and Johnson & Johnson pays a 2.06% dividend while Sunrun Inc pays none. Which is the better fit depends on your goals.
| JNJ | RUN | |
|---|---|---|
Market Cap | $626.09B | $2.42B |
Volume | 6,156,228 | — |
Sector | Health | Technology |
52-Week High | $267.24 | $21.41 |
52-Week Low | $172.78 | $9.38 |
Enterprise Value | $654.37B | $16.93B |
Dividend Yield | 2.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.
Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.
Sunrun (RUN) trades at $10.19, up 3.24% today, but faces bearish technical signals despite strong earnings beats in recent quarters. The company shows solid valuation metrics with P/E of 6.82 and P/S of 0.78, though cash flow remains negative from operations. Recent news highlights mixed sentiment with Q2 earnings beating expectations but guidance cuts weighing on investor confidence.
The outlook remains cautious with analyst consensus bullish (62% buy ratings) and a $14.38 price target suggesting 41% upside potential. Key risks include negative operating cash flow, high debt levels, and competitive pressures in the solar industry. The stock offers value opportunity but requires careful monitoring of cash generation improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →
